Literature DB >> 28376685

Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma.

Yu Liu1, Lili Han2,3, Yahui Bai1, Wei Du1, Bo Yang1.   

Abstract

miRNAs were reported as oncogene or tumour suppressors in various cancers and played important roles in tumour development and progression. Dysregulated miR-133 has been reported in several cancers, however, the expression and biological function of miR-133 in glioma remained unclear. In this study, we found that miR-133 expression level was significantly decreased in glioma tissues and cell lines by RT-qPCR. Then miR-133 mimics were used to evaluate the effects of miR-133 on cell proliferation and invasion in vitro. We found that overexpressed miR-133 could significantly suppress cell growth, and invasion in U87 cells. Additionally, we found that forkhead box C1 (FOXC1) was overexpressed in glioma tissue and it was directly regulated by miR-133. Overall, this study is the first proof to demonstrate that miR-133 function as tumour suppressor in glioma and inhibit cell proliferation and invasioned by directly targeting FOXC1, implying miR-133 as a potential therapeutic target for glioma.

Entities:  

Keywords:  FOXC1; Glioma; invasion; miR-133; proliferation

Mesh:

Substances:

Year:  2017        PMID: 28376685     DOI: 10.1080/21691401.2017.1304551

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  11 in total

1.  MiR-200a inhibits cell proliferation and EMT by down-regulating the ASPH expression levels and affecting ERK and PI3K/Akt pathways in human hepatoma cells.

Authors:  Wei-Feng Yao; Jun-Wei Liu; Dong-Sheng Huang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

2.  LPP and RYR2 Gene Polymorphisms Correlate with the Risk and the Prognosis of Astrocytoma.

Authors:  Qu Chen; Yao Sun; Jiamin Wu; Zichao Xiong; Fanglin Niu; Tianbo Jin; Qiujian Zhao
Journal:  J Mol Neurosci       Date:  2019-08-23       Impact factor: 3.444

Review 3.  FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles.

Authors:  Zhi Yang; Shuai Jiang; Yicheng Cheng; Tian Li; Wei Hu; Zhiqiang Ma; Fulin Chen; Yang Yang
Journal:  Ther Adv Med Oncol       Date:  2017-11-23       Impact factor: 8.168

4.  FOXC1 silencing inhibits the epithelial‑to‑mesenchymal transition of glioma cells: Involvement of β‑catenin signaling.

Authors:  Qinchen Cao; Xinxin Wang; Yonggang Shi; Mingzhi Zhang; Jing Yang; Meilian Dong; Yin Mi; Zhigang Zhang; Ke Liu; Li Jiang; Na Wang; Ping Wang
Journal:  Mol Med Rep       Date:  2018-11-13       Impact factor: 2.952

5.  Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner.

Authors:  Monika Kuciak; Christophe Mas; Isabel Borges; Pilar Sánchez-Gómez; Ariel Ruiz I Altaba
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

6.  MicroRNA-133 Targets Phosphodiesterase 1C in Drosophila and Human Oral Cancer Cells to Regulate Epithelial-Mesenchymal Transition.

Authors:  Ji Eun Jung; Joo Young Lee; Hae Ryoun Park; Ji Wan Kang; Yun Hak Kim; Ji Hye Lee
Journal:  J Cancer       Date:  2021-07-03       Impact factor: 4.207

7.  MiR-133 Targets YES1 and Inhibits the Growth of Triple-Negative Breast Cancer Cells.

Authors:  Guochen Zhang; Junlan Wang; Ruilin Zheng; Beibei Song; Li Huang; Yujiang Liu; Yating Hao; Xiangdong Bai
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

8.  miR-133a-3p promotes apoptosis and induces cell cycle arrest by targeting CREB1 in retinoblastoma.

Authors:  Jianchang Li; Xiuming Liu; Wenqi Wang; Chaopeng Li
Journal:  Arch Med Sci       Date:  2019-07-25       Impact factor: 3.318

Review 9.  Role of MicroRNAs Induced by Chinese Herbal Medicines Against Hepatocellular Carcinoma: A Brief Review.

Authors:  Ge Guo; Juhua Zhou; Xiaogaung Yang; Jiang Feng; Yanxia Shao; Tingting Jia; Qingrong Huang; Yanmin Li; Yin Zhong; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Integr Cancer Ther       Date:  2018-10-20       Impact factor: 3.279

10.  miR-149 Suppresses the Proliferation and Metastasis of Human Gastric Cancer Cells by Targeting FOXC1.

Authors:  Dan Li; Yunqing Zhang; Yulong Li; Xiaofei Wang; Fenghui Wang; Juan Du; Huahua Zhang; Haiyan Shi; Yanfeng Wang; Yi Gao; Yun Feng; Jing Yan; Yajuan Xue; Yang Yang; Jing Zhang
Journal:  Biomed Res Int       Date:  2021-12-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.